Mohammed Nawar S, Ali Zahraa Q, Mohamed Aseel Sameer, Mirza Sazan Abdulwahab
Department of Biochemistry, College of Medicine, University of Baghdad, Baghdad, Iraq.
Department of Anatomy, College of Medicine, University of Baghdad, Baghdad, Iraq.
Toxicol Rep. 2024 Nov 8;13:101806. doi: 10.1016/j.toxrep.2024.101806. eCollection 2024 Dec.
Methamphetamine (METH) is a powerful stimulant that affects neurochemical processes controlling heart rate, appetite, blood pressure, body temperature, and wakefulness, making it highly susceptible to abuse. Liver enzymes such as ALT, AST, ALP, and GGT are crucial for liver function. Albumin, a protein synthesized by healthy liver cells, serves as an indicator of chronic liver disease. Additionally, hepatocytes produce bile acids, which are essential for the secretion of bile salts into the bile canaliculi. Disruption in this secretion results in the accumulation of bile salts in the canaliculi, leading to intrahepatic cholestasis. METH-induced liver toxicity involves disruptions in hepatic metabolism, oxidative stress, and increased body temperature, affecting cellular processes such as cell division and the cell cycle and potentially accelerating liver cell apoptosis. The study explores the link between liver toxicity and hepatocyte damage in Iraqi males suffering from addiction. This is a case-control study, conducted at Ibn-Rushed Psychiatric Hospital in Baghdad from July 2023 to February 2024, involved 196 males, with addiction durations exceeding 24 months with varying degrees of methamphetamine (METH) addiction. The study included 187 healthy male controls with no history of drug addiction. Participants were aged 18-40 years. Diagnosis was confirmed using a drug test screening card administered by a specialist. The study included liver function tests (ALT, AST, ALP, and GGT), total bilirubin, and albumin concentration assessments. Significant differences were observed between the addicts and controls, particularly a marked decrease in serum albumin concentration in the addicted males. The ROC curve classification model at various thresholds demonstrated that liver enzymes, especially ALT, ALP, and GGT, exhibited increased sensitivity to METH addiction. A histopathological examination was conducted on a deceased 38-year-old male who had a six-year history of chronic amphetamine addiction to confirm liver injury and the resulting elevation of liver enzymes. The findings of this study indicate that METH greatly affects liver function, suggested to the importance of following a preventative measures and effective treatment approaches for monitoring METH addiction progress.
甲基苯丙胺(METH)是一种强效兴奋剂,会影响控制心率、食欲、血压、体温和清醒状态的神经化学过程,极易被滥用。谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(ALP)和γ-谷氨酰转肽酶(GGT)等肝脏酶类对肝功能至关重要。白蛋白是由健康肝细胞合成的一种蛋白质,可作为慢性肝病的指标。此外,肝细胞会产生胆汁酸,胆汁酸对于将胆盐分泌到胆小管中至关重要。这种分泌过程的中断会导致胆盐在胆小管中积聚,从而引发肝内胆汁淤积。METH诱导的肝毒性涉及肝脏代谢紊乱、氧化应激和体温升高,影响细胞分裂和细胞周期等细胞过程,并可能加速肝细胞凋亡。该研究探讨了伊拉克成瘾男性的肝毒性与肝细胞损伤之间的联系。这是一项病例对照研究,于2023年7月至2024年2月在巴格达的伊本·拉什德精神病医院进行,涉及196名男性,成瘾时间超过24个月,甲基苯丙胺(METH)成瘾程度各异。该研究纳入了187名无药物成瘾史的健康男性对照。参与者年龄在18至40岁之间。通过由专家管理的药物检测筛查卡进行确诊。该研究包括肝功能测试(ALT、AST、ALP和GGT)、总胆红素和白蛋白浓度评估。在成瘾者和对照组之间观察到了显著差异,尤其是成瘾男性的血清白蛋白浓度明显降低。不同阈值下的ROC曲线分类模型表明,肝脏酶类,尤其是ALT、ALP和GGT,对METH成瘾表现出更高的敏感性。对一名有六年慢性苯丙胺成瘾史的38岁男性死者进行了组织病理学检查,以确认肝损伤及由此导致的肝脏酶升高。该研究结果表明,METH对肝功能有很大影响,这提示了采取预防措施和有效治疗方法以监测METH成瘾进展的重要性。